High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care center

OBJECTIVES: Prostate cancer incidence is increasing in the Middle East (ME); however, the data of stage at the diagnosis and treatment outcomes are lacking. In developed countries, the incidence of de novo metastatic prostate cancer ranges between 4% and 14%. We hypothesized that the rates of presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Daher, Marilyne, Telvizian, Talar, Dagher, Christelle, Abdul-Sater, Zahi, Massih, Sarah Abdel, Chediak, Alissar EL, Charafeddine, Maya, Shahait, Mohammed, Alameddine, Raafat, Temraz, Sally, Geara, Fady, Youssef, Bassem, El Hajj, Albert, Nasr, Rami, Wazzan, Wassim, Bulbul, Muhammad, Khauli, Raja, Shamseddine, Ali, Mukherji, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525480/
https://www.ncbi.nlm.nih.gov/pubmed/34759656
http://dx.doi.org/10.4103/UA.UA_47_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525480/
https://www.ncbi.nlm.nih.gov/pubmed/34759656
http://dx.doi.org/10.4103/UA.UA_47_20

Ejemplares similares